Tirzepatide
Tirzepatide belongs to the dual GIP and GLP-1 receptor agonist class, offering a unique approach to blood sugar control and weight management. By activating these receptors, tirzepatide helps regulate glucose levels, reduces appetite, and extends the feeling of fullness after meals.*
Product overview
Lowers A1C Levels
Helps you feel full faster, longer
Helps the body remove excess sugar from the blood
How to take
One subcutaneous injection weekly as directed by your Healthcare provider
Side Effects
Common side effects with Tirzepatide include:
Redness & itching at the injection site
Loss of appetite
Tiredness
Nausea
Upset stomach
Diarrhea, or constipation may occur
*Tirzepatide is not FDA-approved for weight loss, but may be prescribed if a provider deems it appropriate